• Vorinostat (SAHA, MK0683) Assay Guide

  2026-08-13

  A scenario-driven guide to using Vorinostat (SAHA, MK0683), SKU A4084, in cell viability, proliferation, and apoptosis workflows. It connects HDAC biology with practical solvent control, dose selection, orthogonal readouts, and vendor evaluation for reproducible cancer biology research.

• D-N-Acetylgalactosamine: Workflow Guide

  2026-08-13

  D-N-Acetylgalactosamine provides a defined, water- or DMSO-soluble reagent for workflows examining glycoprotein constituents, brain heteropolysaccharides, and glycosylation-related measurements. It is not appropriate for protocols requiring ethanol solubility or long-term storage of prepared solutions, and the guidance below should be treated as product-dossier and workflow practice rather than direct paper evidence.

• ONX-0914: A Subtype-Aware Proteasome Study

  2026-08-12

  ONX-0914 and PR-957 provide a selective way to interrogate LMP7-dependent immunoproteasome biology. This article connects inhibitor selectivity with breast cancer proteasome heterogeneity and translates that insight into more informative assay decisions.

• Alcian Blue & Nuclear Fast Red Staining Kit

  2026-08-12

  The Alcian Blue & Nuclear Fast Red Staining Kit pH2.5 combines acid mucin visualization with nuclear contrast for more interpretable histology. This guide explains the chemistry, assay limits, and decision framework for chondrogenic differentiation and mucopolysaccharide analysis.

• D-N-Acetylgalactosamine: Brain Glycoprotein Guide

  2026-08-11

  This technical guide explains how to use D-N-Acetylgalactosamine as a defined, water-compatible reagent for brain glycoprotein and glycosylation workflows. It is appropriate for aqueous or DMSO-based preparation, but not for ethanol-based protocols or long-term storage of prepared solutions.

• GW4064: Practical FXR Activation Workflows

  2026-08-11

  GW4064 connects high-specificity FXR pharmacology with practical studies of bile acid, lipid, inflammatory, and fibrotic signaling. This guide translates receptor activation into reproducible workflows, including an LX-2 cell model that links FXR/TLR4 regulation with ferroptosis and collagen deposition.

• 3X FLAG Peptide: Workflows for DPF2 Studies

  2026-08-10

  Use the 3X FLAG peptide to build sensitive, competition-based workflows for recombinant protein purification, isoform comparison, immunodetection, and structural biology. Applied to DPF2 research, it helps separate expression, capture, and chromatin-association questions without assuming that alternative isoforms behave identically.

• ABT-263 (Navitoclax) Workflow for Apoptosis Studies

  2026-08-09

  Build a practical ABT-263 workflow around mitochondrial priming, caspase activation, and combination-response profiling. The approach translates recent colorectal cancer organoid findings into adaptable cell, organoid, and pediatric leukemia experiments while emphasizing controls, solvent handling, and resistance analysis.

• PERK–JAK1–STAT3 Signaling in Disc Pyroptosis

  2026-08-08

  The reference study identifies a PERK/eIF2α/ATF4-dependent route by which unresolved endoplasmic reticulum stress activates JAK1–STAT3 signaling and intensifies pyroptosis in nucleus pulposus cells. Its findings connect ER stress to inflammatory cell death in intervertebral disc degeneration and provide a mechanistic framework for testing pathway-specific interventions.

• Mitoxantrone HCl: Beyond Topo-II Inhibition

  2026-08-07

  Mitoxantrone HCl is more than a benchmark DNA topoisomerase II inhibitor. Emerging evidence shows that it can also disrupt the ERα DBD–LBD interface, offering translational researchers a framework for separating DNA-damage biology from allosteric receptor degradation in resistance-focused cancer models.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-08-07

  Schwartz's dissertation introduces refined in vitro approaches that distinguish between drug-induced growth inhibition and cell death in cancer models. This innovation enables more accurate assessment of anticancer compounds, supporting improved experimental design and interpretation in cancer biology.

• Mechanical Activation of GABAB Receptors: Integrin-Mediated

  2026-08-06

  This study reveals that GABAB receptors can be directly activated by mechanical forces such as traction and shear stress, independent of their canonical ligand, GABA. The findings show a new integrin-mediated mechanism of GPCR activation with important implications for understanding mechanotransduction in neural and glial cells.

• LPS-Mediated Macrophage Protection via System Xc− and ABCC1

  2026-08-06

  This study uncovers how lipopolysaccharide (LPS) selectively protects macrophages from antitumor drug toxicity by upregulating the cystine/glutamate antiporter (system Xc−) and engaging ABCC1-mediated transport, independent of canonical TLR4 or caspase-11 signaling. These findings clarify the molecular underpinnings of immune cell resilience during chemotherapy and highlight mechanistic targets for reducing collateral immune toxicity.

• SB743921: Applied Protocols for Kinesin Spindle Protein Inhi

  2026-08-05

  SB743921 stands out as a highly selective kinesin spindle protein inhibitor, enabling precise control of mitotic arrest and apoptosis in cancer cell models. This guide delivers actionable workflows, troubleshooting advice, and evidence-based insights to maximize the reliability and interpretability of anti-proliferative assays.

• Standardized Whole-Blood Stimulation for Immunometabolism An

  2026-08-05

  The reference study introduces a standardized protocol for analyzing immune responses in human whole blood by modulating metabolic pathways. This innovation enables reproducible, large-scale assessment of how metabolic inhibitors like Mycophenolic acid influence cytokine production, providing critical insights for immunometabolism research.

16369 records 1/1092 page Next 12345 下5页 Last page